SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2023-08-18 11:28
Tx date 2023-08-15 		$ONC
Oncolytics Biotech Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$82,800
+30,000 vol
$2.76 each 		75,000
Filed 2023-05-05 23:34
Tx date 2023-04-25 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+210,000 vol 		210,000
Filed 2022-09-26 09:18
Tx date 2022-09-22 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants 		$3,500
+10,000 vol
$0.35 each 		284,728
Filed 2022-09-26 09:13
Tx date 2022-09-22 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants 		$-3,500
-10,000 vol
$0.35 each 		0
Filed 2022-06-23 10:00
Tx date 2022-06-20 		$ONC
Oncolytics Biotech Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$51,299
+45,000 vol
$1.14 each 		45,000
Filed 2022-06-23 09:57
Tx date 2022-06-16 		$ONC
Oncolytics Biotech Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-02-08 19:29
Tx date 2022-02-08 		$DMAC
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
99 - Correction of information
-475,000 vol 		60,649
Filed 2022-02-08 19:26
Tx date 2022-02-08 		$DMAC
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Deferred Share Units
99 - Correction of information
-73,150 vol 		36,259
Filed 2022-02-08 19:23
Tx date 2022-01-03 		$DMAC
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights 		$60,047
+16,773 vol
$3.58 each 		109,409
Filed 2022-02-08 19:15
Tx date 2021-01-01 		$DMAC
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights 		$62,004
+7,534 vol
$8.23 each 		92,636
Filed 2022-02-08 19:13
Tx date 2021-01-01 		$DMAC
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Deferred Share Units
11 - Acquisition or disposition carried out privately 		$62,004
+7,534 vol
$8.23 each
Filed 2021-01-05 19:38
Tx date 2021-01-01 		$DMAC
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Deferred Share Units
11 - Acquisition or disposition carried out privately 		$63,741
+7,745 vol
$8.23 each
Filed 2021-12-16 21:36
Tx date 2021-12-09 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Rights Deferred Share Units
56 - Grant of rights
+260,000 vol 		1,285,001
Filed 2021-07-23 20:51
Tx date 2021-07-15 		$DMAC
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$34,190
+9,393 vol
$3.64 each 		535,649
Filed 2021-07-20 17:49
Tx date 2021-07-15 		$DMAC
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$34,190
+9,393 vol
$3.64 each
Filed 2021-07-20 17:49
Tx date 2021-07-15 		$DMAC
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$34,190
+9,393 vol
$3.64 each 		535,649
Filed 2021-02-08 11:15
Tx date 2021-02-08 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants
+50,000 vol 		274,728
Filed 2021-02-08 11:14
Tx date 2021-02-08 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
-50,000 vol 		10,000
Filed 2021-01-12 12:21
Tx date 2021-01-08 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-134,270.9865
-8,505 vol
$15.79 each 		0
Filed 2021-01-12 12:19
Tx date 2021-01-08 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$78,246
+8,505 vol
$9.20 each 		8,505
Filed 2021-01-12 12:12
Tx date 2021-01-08 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-78,246
-8,505 vol
$9.20 each 		173,492
Filed 2021-01-05 19:38
Tx date 2021-01-01 		$DMAC
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Deferred Share Units
11 - Acquisition or disposition carried out privately 		$63,741
+7,745 vol
$8.23 each 		92,847
Filed 2021-01-04 13:32
Tx date 2020-12-31 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-398,751.45
-26,970 vol
$14.79 each 		0
Filed 2021-01-04 13:30
Tx date 2020-12-31 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$224,929
+26,970 vol
$8.34 each 		26,970
Filed 2021-01-04 13:29
Tx date 2020-12-31 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-62,836.25
-4,250 vol
$14.79 each 		0
Filed 2021-01-04 13:28
Tx date 2020-12-31 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$31,875
+4,250 vol
$7.50 each 		4,250
Filed 2021-01-04 13:26
Tx date 2020-12-31 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-224,929.80
-26,970 vol
$8.34 each 		181,997
Filed 2021-01-04 13:24
Tx date 2020-12-31 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-31,875
-4,250 vol
$7.50 each 		208,967
Filed 2020-12-28 16:34
Tx date 2020-12-23 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+180,000 vol 		287,893
Filed 2020-12-18 20:00
Tx date 2020-12-18 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-827,940.5888
-65,104 vol
$12.72 each 		0
Filed 2020-12-18 19:59
Tx date 2020-12-18 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$275,389
+65,104 vol
$4.23 each 		65,104
Filed 2020-12-18 19:58
Tx date 2020-12-16 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-160,186.382
-14,162 vol
$11.31 each 		0
Filed 2020-12-18 19:57
Tx date 2020-12-16 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$5,381
+14,162 vol
$0.38 each 		14,162
Filed 2020-12-18 19:56
Tx date 2020-12-15 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-244,764.98
-21,046 vol
$11.63 each 		0
Filed 2020-12-18 19:55
Tx date 2020-12-15 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$7,997
+21,046 vol
$0.38 each 		21,046
Filed 2020-12-18 19:53
Tx date 2020-12-15 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-501,159.96
-43,092 vol
$11.63 each 		0
Filed 2020-12-18 19:52
Tx date 2020-12-15 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$33,180
+43,092 vol
$0.77 each 		43,092
Filed 2020-12-18 19:51
Tx date 2020-12-18 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-275,389.92
-65,104 vol
$4.23 each 		213,217
Filed 2020-12-18 19:50
Tx date 2020-12-16 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-5,381.56
-14,162 vol
$0.38 each 		278,321
Filed 2020-12-18 19:49
Tx date 2020-12-15 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-7,997.48
-21,046 vol
$0.38 each 		292,483
Filed 2020-12-18 19:47
Tx date 2020-12-15 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-33,180.84
-43,092 vol
$0.77 each 		313,529
Filed 2020-12-18 19:06
Tx date 2020-12-14 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-1,255,613.0784
-106,908 vol
$11.74 each 		0
Filed 2020-12-18 19:05
Tx date 2020-12-14 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
51 - Exercise of options 		$82,319
+106,908 vol
$0.77 each 		106,908
Filed 2020-12-18 19:03
Tx date 2011-08-25 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 18:21
Tx date 2020-12-14 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
51 - Exercise of options 		$-82,319.16
-106,908 vol
$0.77 each 		356,621
Filed 2020-12-18 17:44
Tx date 2020-09-29 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
90 - Change in the nature of ownership
+463,529 vol 		463,529
Filed 2020-12-18 17:42
Tx date 2011-08-25 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 17:40
Tx date 2020-09-29 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
90 - Change in the nature of ownership
-463,529 vol 		107,893
Filed 2020-12-18 17:34
Tx date 2011-08-25 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 17:33
Tx date 2020-09-29 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
90 - Change in the nature of ownership
-463,529 vol
Filed 2020-12-18 16:48
Tx date 2011-08-25 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report 		463,529
Filed 2020-12-18 16:48
Tx date 2011-08-25 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Holder: BMO Nesbitt Burns Inc (Control or Direction)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-18 16:44
Tx date 2020-09-29 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
90 - Change in the nature of ownership
-463,529 vol
Filed 2020-12-18 16:44
Tx date 2020-09-29 		$TRIL
Trillium Therapeutics Inc. 		Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
90 - Change in the nature of ownership
-463,529 vol 		107,893
Filed 2020-11-13 09:15
Tx date 2018-11-14 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
+50,000 vol 		50,000
Filed 2018-11-15 15:38
Tx date 2018-11-14 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
+50,000 vol
Filed 2020-09-24 13:10
Tx date 2020-09-22 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption
+10,000 vol 		60,000
Filed 2020-09-24 13:08
Tx date 2020-09-22 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$3,000
+10,000 vol
$0.30 each 		224,728
Filed 2020-06-02 17:58
Tx date 2020-06-01 		$DMAC
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+13,306 vol 		526,256
Filed 2020-06-02 17:57
Tx date 2020-06-01 		$DMAC
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights
+8,102 vol 		85,102
Filed 2019-11-12 10:38
Tx date 2019-11-07 		$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$49,400
+130,000 vol
$0.38 each 		571,422
Filed 2019-09-18 10:19
Tx date 2019-09-13 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Rights Deferred Share Units
56 - Grant of rights
+740,056 vol 		1,025,001
Filed 2019-06-27 11:54
Tx date 2019-06-24 		$DMA
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+12,950 vol 		512,950
Filed 2019-05-27 12:54
Tx date 2019-05-10 		$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$115,500
+150,000 vol
$0.77 each 		441,422
Filed 2019-03-11
Tx date 2019-02-28 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-150,000 vol 		0
Filed 2018-12-11
Tx date 2015-10-23 		$DMA
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-12-11
Tx date 2018-12-11 		$DMA
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
+2,250 vol 		2,250
Filed 2018-11-15
Tx date 2018-11-14 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Special Warrants
54 - Exercise of warrants 		$-12,500
-50,000 vol
$0.25 each 		0
Filed 2018-11-15
Tx date 2018-11-14 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
+50,000 vol 		50,000
Filed 2018-11-15
Tx date 2018-11-14 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants 		$12,500
+50,000 vol
$0.25 each 		214,728
Filed 2018-11-09
Tx date 2018-11-08 		$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$528,750
+125,000 vol
$4.23 each 		291,422
Filed 2018-07-17
Tx date 2012-04-19 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Special Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2018-07-17
Tx date 2018-07-13 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Special Warrants
16 - Acquisition or disposition under a prospectus exemption 		$12,500
+50,000 vol
$0.25 each 		50,000
Filed 2018-07-12
Tx date 2018-04-17 		$DMA
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$33,600
+60,000 vol
$0.56 each 		500,000
Filed 2018-07-04
Tx date 2018-06-30 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants
-40,000 vol 		0
Filed 2017-11-13
Tx date 2017-11-09 		$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$298,045
+24,390 vol
$12.22 each 		166,422
Filed 2017-09-14
Tx date 2017-08-14 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Rights Deferred Share Units
56 - Grant of rights
+59,945 vol 		284,945
Filed 2017-06-23
Tx date 2017-06-19 		$DMA
DiaMedica Therapeutics Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+100,000 vol 		440,000
Filed 2017-04-18
Tx date 2017-04-18 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$8,951
+49,728 vol
$0.18 each 		164,728
Filed 2017-04-18
Tx date 2017-04-18 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-8,951.04
-49,728 vol
$0.18 each 		150,000
Filed 2017-04-17
Tx date 2017-04-13 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$29,970
+166,500 vol
$0.18 each 		281,500
Filed 2017-04-17
Tx date 2017-04-17 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-48.96
-272 vol
$0.18 each 		199,728
Filed 2017-04-17
Tx date 2017-04-17 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$48.96
+272 vol
$0.18 each 		115,272
Filed 2017-04-17
Tx date 2017-04-17 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-68.00
-272 vol
$0.25 each 		115,000
Filed 2017-04-17
Tx date 2017-04-13 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-41,625
-166,500 vol
$0.25 each 		115,000
Filed 2017-04-17
Tx date 2017-04-13 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-29,970
-166,500 vol
$0.18 each 		200,000
Filed 2017-04-12
Tx date 2017-04-11 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-8,375
-33,500 vol
$0.25 each 		115,000
Filed 2017-04-12
Tx date 2017-04-11 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$6,030
+33,500 vol
$0.18 each 		148,500
Filed 2017-04-12
Tx date 2017-04-11 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-6,030
-33,500 vol
$0.18 each 		366,500
Filed 2016-12-02
Tx date 2016-11-28 		$DMA
DiaMedica Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+100,000 vol 		340,000
Filed 2016-12-02
Tx date 2016-11-28 		$DMA
DiaMedica Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights 		$14,630
+77,000 vol
$0.19 each 		77,000
Filed 2016-12-02
Tx date 2015-10-23 		$DMA
DiaMedica Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2016-11-10
Tx date 2016-11-09 		$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$131,247
+14,266 vol
$9.20 each 		142,032
Filed 2016-11-10
Tx date 2016-08-25 		$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-12,510
-417 vol
$30.00 each 		127,766
Filed 2016-07-06
Tx date 2016-06-30 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$10,000
+40,000 vol
$0.25 each 		115,000
Filed 2016-07-06
Tx date 2012-04-19 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		75,000
Filed 2016-07-06
Tx date 2012-04-19 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2016-07-06
Tx date 2016-06-30 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption
+40,000 vol 		40,000
Filed 2016-05-30
Tx date 2016-05-27 		$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+30,171 vol 		128,183
Filed 2016-03-14
Tx date 2016-03-14 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Rights Deferred Share Units
56 - Grant of rights
+100,000 vol 		225,000
Filed 2015-12-15
Tx date 2015-10-23 		$DMA
DiaMedica Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2015-12-15
Tx date 2015-12-01 		$DMA
DiaMedica Inc. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$36,000
+240,000 vol
$0.15 each 		240,000
Filed 2015-11-20
Tx date 2015-11-19 		$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+30,171 vol 		98,012
Filed 2015-06-29
Tx date 2012-04-19 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Rights Deferred Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2015-06-29
Tx date 2015-06-25 		$SVA
Sernova Corp. 		Parsons, James Todd
4 - Director of Issuer
Direct Ownership
Rights Deferred Share Units
56 - Grant of rights
+125,000 vol 		125,000
Filed 2015-05-22
Tx date 2014-11-14 		$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
+4,250 vol 		1,899,875
Filed 2015-05-22
Tx date 2014-11-14 		$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-127,514 vol 		1,895,625
Filed 2015-05-22
Tx date 2014-11-14 		$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
+417 vol 		2,023,139
Filed 2015-05-22
Tx date 2014-11-14 		$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
+36,204 vol 		849,960
Filed 2015-05-22
Tx date 2014-11-14 		$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-809,089 vol 		40,871
Filed 2015-05-22
Tx date 2014-11-14 		$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
+26,970 vol 		67,841
Filed 2015-05-22
Tx date 2014-11-14 		$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-12,500 vol 		2,022,722
Filed 2015-05-22
Tx date 2014-11-14 		$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) 		Parsons, James Todd
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-1,086,119 vol 		813,756